APEX2 and breast carcinoma: Whereas there were no significant correlations of APE2 to BRCA1 and BRCA2 in breast cancer (Fig. 4), kidney cancer samples exhibited a negative correlation of APE2-BRCA2 and a positive correlation of APE2-BRCA1 (Fig. S18, and Table S5).